121 related articles for article (PubMed ID: 30168308)
1. Drug-eluting stents for the treatment of complex femoro-popliteal disease: a systematic review and meta-analysis.
Katsogridakis E; Ballance L; Cawley O; Antoniou GA
J Cardiovasc Surg (Torino); 2022 Jun; 63(3):299-307. PubMed ID: 30168308
[TBL] [Abstract][Full Text] [Related]
2. Angioplasty or bare metal stent versus drug-eluting endovascular treatment in femoropopliteal artery disease: a systematic review and meta-analysis.
Varetto G; Gibello L; Boero M; Frola E; Peretti T; Spalla F; Verzini F; Rispoli P
J Cardiovasc Surg (Torino); 2019 Oct; 60(5):546-556. PubMed ID: 31527577
[TBL] [Abstract][Full Text] [Related]
3. ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions.
Bosiers M; Setacci C; De Donato G; Torsello G; Silveira PG; Deloose K; Scheinert D; Veroux P; Hendriks J; Maene L; Keirse K; Navarro T; Callaert J; Eckstein HH; Teβarek J; Giaquinta A; Wauters J
J Endovasc Ther; 2020 Apr; 27(2):287-295. PubMed ID: 31997715
[No Abstract] [Full Text] [Related]
4. A single center experience of Zilver PTX for femoro-popliteal lesions.
Kang WY; Campia U; Didier RJ; Kiramijyan S; Koifman E; Negi SI; Lipinski MJ; Baker NC; Escarcega RO; Torguson R; Waksman R; Bernardo NL
Cardiovasc Revasc Med; 2016 Sep; 17(6):399-403. PubMed ID: 27496591
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions.
Tsujimura T; Takahara M; Iida O; Soga Y; Katsuki T; Fujihara M; Kawasaki D; Kozuki A; Mano T
J Vasc Surg; 2021 Jun; 73(6):1998-2008.e1. PubMed ID: 33347998
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel exposure and long-term mortality of patients treated with the Zilver PTX drug-eluting stent.
Stern JR; Tran K; Chandra V; Harris EJ; Lee JT
Vascular; 2021 Aug; 29(4):567-573. PubMed ID: 33054678
[TBL] [Abstract][Full Text] [Related]
7. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
[TBL] [Abstract][Full Text] [Related]
8. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
9. Increased mortality with paclitaxel-eluting stents is driven by lesion length.
Mathlouthi A; Yei KS; Naazie I; Bertges DJ; Malas MB
J Vasc Surg; 2021 Feb; 73(2):548-553.e2. PubMed ID: 32615286
[TBL] [Abstract][Full Text] [Related]
10. ZILVERPASS Study: ZILVER PTX Stent vs. Bypass Surgery in Femoropopliteal Lesions, 3 year results and economic analysis.
Bosiers M; DE Donato G; Torsello G; Galvagni Silveira P; Deloose K; Scheinert D; Veroux P; Hendriks J; Maene L; Keirse K; Navarro T; Callaert J; Eckstein HH; Tessarek J; Giaquinta A; van den Eynde W; Verbist J; Wahl-Gravsen J; Bosiers MJ
J Cardiovasc Surg (Torino); 2023 Aug; 64(4):413-421. PubMed ID: 37162238
[TBL] [Abstract][Full Text] [Related]
11. Japanese Patients Treated in the IMPERIAL Randomized Trial Comparing Eluvia and Zilver PTX Stents.
Soga Y; Fujihara M; Iida O; Kawasaki D; Hirano K; Yokoi H; Miyamoto A; Kichikawa K; Nakamura M; Ohki T; Diaz-Cartelle J; Gray WA; Müller-Hülsbeck S
Cardiovasc Intervent Radiol; 2020 Feb; 43(2):215-222. PubMed ID: 31690980
[TBL] [Abstract][Full Text] [Related]
12. Provisional Stenting Using the Zilver PTX Drug-Eluting Stent After Drug-Coated Balloon Angioplasty: Initial Experience From the Double Drug Dose "3D" Study.
Fanelli F; Cannavale A; Citone M; Santoni M; Gazzetti M; Falcone GM; Miele V
J Endovasc Ther; 2020 Feb; 27(1):34-41. PubMed ID: 31637956
[No Abstract] [Full Text] [Related]
13. The Zilver® PTX® Single Arm Study: 12-month results from the TASC C/D lesion subgroup.
Bosiers M; Peeters P; Tessarek J; Deloose K; Strickler S;
J Cardiovasc Surg (Torino); 2013 Feb; 54(1):115-22. PubMed ID: 23296421
[TBL] [Abstract][Full Text] [Related]
14. Iliac Artery Stenting Combined with Ipsilateral Open Femoro-Popliteal Revascularization and Its Effect on Bypass Patency.
Piazza M; Squizzato F; Lepidi S; Menegolo M; Grego F; Antonello M
Ann Vasc Surg; 2017 Oct; 44():282-288. PubMed ID: 28479462
[TBL] [Abstract][Full Text] [Related]
15. A Polymer-Free Paclitaxel-Eluting Stent Versus a Bare-Metal Stent for De Novo Femoropopliteal Lesions: The BATTLE Trial.
Gouëffic Y; Sauguet A; Desgranges P; Feugier P; Rosset E; Ducasse E; Kaladji A; Salomon du Mont L; Pernès JM; Commeau P; Lermusiaux P; Leclere B; Guyomarc'h B; Hoffmann CT; Maurel B
JACC Cardiovasc Interv; 2020 Feb; 13(4):447-457. PubMed ID: 32081238
[TBL] [Abstract][Full Text] [Related]
16. A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial.
Gray WA; Keirse K; Soga Y; Benko A; Babaev A; Yokoi Y; Schroeder H; Prem JT; Holden A; Popma J; Jaff MR; Diaz-Cartelle J; Müller-Hülsbeck S;
Lancet; 2018 Oct; 392(10157):1541-1551. PubMed ID: 30262332
[TBL] [Abstract][Full Text] [Related]
17. Primary Patency of Long-Segment Femoropopliteal Artery Lesions in Patients with Peripheral Arterial Occlusive Disease Treated with Paclitaxel-Eluting Technology.
Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
Ann Vasc Surg; 2020 Jul; 66():595-600. PubMed ID: 31863948
[TBL] [Abstract][Full Text] [Related]
18. Real-world outcomes of Cook Zilver PTX in femoro-popliteal district from multicenter experience.
Bianchini Massoni C; Strozzi F; Epifani E; Zenunaj G; Ucci A; Paladini I; Gasbarro V; Tusini N; Freyrie A
Int Angiol; 2023 Feb; 42(1):9-18. PubMed ID: 36534022
[TBL] [Abstract][Full Text] [Related]
19. Bare Metal Versus Paclitaxel-Eluting Stents for Long Femoropopliteal Lesions: Prospective Cohorts Comparison Using a Propensity Score-Matched Analysis.
Vent PA; Kaladji A; Davaine JM; Guyomarch B; Chaillou P; Costargent A; Quillard T; Gouëffic Y
Ann Vasc Surg; 2017 Aug; 43():166-175. PubMed ID: 28300676
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Drug-Eluting Stent with Bare-Metal Stent Implantation in Femoropopliteal Artery Disease: A Systematic Review and Meta-Analysis.
Ding Y; Zhou M; Wang Y; Cai L; Shi Z
Ann Vasc Surg; 2018 Jul; 50():96-105. PubMed ID: 29514049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
